
    
      Part 1: After an overnight fast of at least 10 hours, subjects will receive a single, oral
      dose of niraparib (unlabeled active pharmaceutical ingredient) on Day 1. Two hours after the
      oral dose, subjects will receive a 15-minute IV infusion of niraparib (labeled pharmaceutical
      ingredient).

      Part 2: After an overnight fast of at least 10 hours, subjects will receive a single, oral
      dose of niraparib, labeled active pharmaceutical ingredient.
    
  